Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med. 2002; 34 (2):207–214. doi: 10.1006/pmed.2001.0972. [ Cross Ref ]...
In high-risk individuals who have had titers checked after primary HB immunization, a small percentage of apparently healthy recipients do not mount a detectable response to the vaccine. This failure to respond is related to factors such as age (>40 years), male gender, smoking, obesity, HIV...
CHA Vaccine Institute aims to further develop CVI-HBV-002 as Korea's first two-dose hepatitis B vaccine, as this approach could offer a viable option for those unresponsive to existing vaccines. "The clinical trial showed high safety and immunization effectiveness, confirming the potential to overc...
Hepatitis B vaccine has been progressively introduced into the Gambian programme of immunization since 1986. Other African countries are considering introduction but require evidence of cost-effectiveness to justify such a decision. The cost of the Expanded Programme on Immunization in The Gambia, which...
To determine the cost-effectiveness of substituting hepatitis A–B vaccine for hepatitis B vaccine when healthcare and public safety workers in the western United States are immunized to protect against occupational exposures to hepatitis B. A cohort of 100,000 hypothetical healthcare and public safet...
A decision-analysis model was used to assess the cost effectivenessof three strategies for preventing hepatitis B infection: (1) vaccinatingeveryone, (2) screening everyone and vaccinating those without evidence ofimmunity, and (3) neither screening nor vaccinating, but responding to knownexposure with...
hepatitis B-related liver cancer, hepatitis B vaccine immunization program, cost analysis, incremental cost-effectiveness ratio, marginal effectiveness References [1] Shimakawa Y, Seck A, Nayagam S, et al. Screening strategies to prevent mother-to-child transmission of hepatitis B in sub-Sahara...
Background: Hepatitis A and B are two of the mostdoi:10.1586/14760584.2016.1150182Marina BakkerEveline M. BungeCinzia MaranoMarc de RidderLaurence De MoerloozeImmunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review [ J]. Expert Rev Vac- cine...
Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nati... Davaalkham,Ojima,Wiersma,... - 《Journal of Epidemiology & Community Health》 - 2007 - 被引量: 37 Protective Efficacy of a Recombinant...
hepatitis B vaccination of infants to interrupt transmission. In 1994, the ACIP expanded the recommendations to include previously unvaccinated children aged 11-12 years.2The percentage of children aged 19-35 months who have received three doses of hepatitis B vaccine has increased substantially from...